检索结果 - Marek Z. Wojtukiewicz

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Enhanced prolidase activity and decreased collagen content in breast cancer tissue

    Enhanced prolidase activity and decreased collagen content in breast cancer tissue 由 Marzanna Cechowska‐Pasko, Jerzy Pałka, Marek Z. Wojtukiewicz

    出版 2006
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    The Hemostatic System and Angiogenesis in Malignancy

    The Hemostatic System and Angiogenesis in Malignancy 由 Marek Z. Wojtukiewicz, Ewa Sierko, Petr Klementt, Janusz Rak

    出版 2001
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis

    Protease-activated receptors (PARs)—biology and role in cancer invasion and metastasis 由 Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Platelets and cancer angiogenesis nexus

    Platelets and cancer angiogenesis nexus 由 Marek Z. Wojtukiewicz, Ewa Sierko, Dominika Hempel, Stephanie C. Tucker, Kenneth V. Honn

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?

    Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past? 由 Marek Z. Wojtukiewicz, Dominika Hempel, Ewa Sierko, Stephanie C. Tucker, Kenneth V. Honn

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Cancer epidemiology in Central and South Eastern European countries

    Cancer epidemiology in Central and South Eastern European countries 由 Eduard Vrdoljak, Marek Z. Wojtukiewicz, Tadeusz Pieńkowski, G. Bodoky, Peter Berzinec, Jindřich Fínek, Vladimir Todorović, Nenad Borojević, Adina Croitoru

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study

    First and Subsequent Cycle Use of Pegfilgrastim Prevents Febrile Neutropenia in Patients With Breast Cancer: A Multicenter, Double-Blind, Placebo-Controlled Phase III Study 由 Charles L. Vogel, Marek Z. Wojtukiewicz, Robert R. Carroll, Sergei Tjulandin, Luis Javier Barajas-Figueroa, Brian L. Wiens, Theresa Neumann, Lee S. Schwartzberg

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue

    PET/MRI-guided GTV delineation during radiotherapy planning in patients with squamous cell carcinoma of the tongue 由 Natalia Samołyk-Kogaczewska, Ewa Sierko, Konrad Zuzda, P. Gugnacki, Piotr Szumowski, Małgorzata Mojsak, Justyna Burzyńska-Śliwowska, Marek Z. Wojtukiewicz, Kamil Szczecina, Dorota Jurgilewicz

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

    Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m2 24 h or 1.3 mg/m2 3 h) to patients with relapsed, platinum-sensitive, advanc... 由 J.M. del Campo, A. Roszak, Mariusz Bidziński, Tudor–Eliade Ciuleanu, Thomas Högberg, Marek Z. Wojtukiewicz, Andrés Poveda, Karin Boman, Anneke M. Westermann, Claudia Lebedinsky

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners

    Inhibitors of immune checkpoints—PD-1, PD-L1, CTLA-4—new opportunities for cancer patients and a new challenge for internists and general practitioners 由 Marek Z. Wojtukiewicz, Magdalena M. Rek, Kamil Karpowicz, Maria Górska, Barbara Polityńska, Anna M. Wojtukiewicz, Marcin Moniuszko, Piotr Radziwon, Stephanie C. Tucker, Kenneth V. Honn

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

    First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial 由 Anton Hagenbeek, Ole Gadeberg, Peter Johnson, Lars Møller Pedersen, Jan Walewski, Andrzej Hellmann, Brian K. Link, Tadeusz Robak, Marek Z. Wojtukiewicz, Michael Pfreundschuh, Michael Kneba, Andreas Engert, Pieter Sonneveld, Mimi Folden Flensburg, Jørgen Holm Petersen, Nedjad Losic, John Radford

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Randomised Phase Ii Study Evaluating, As First-Line Chemotherapy, Weekly Oral Vinorelbine As a Single-Agent Versus Weekly Paclitaxel As a Single-Agent in Estrogen Receptor Positive, Her2-Negative Patients with Advanced Breast Cancer (Norbreast-231 Trial)

    Randomised Phase Ii Study Evaluating, As First-Line Chemotherapy, Weekly Oral Vinorelbine As a Single-Agent Versus Weekly Paclitaxel As a Single-Agent in Estrogen Receptor Positive... 由 Matti Aapro, Elżbieta Starosławska, Serafín Morales, Manuel Ruíz Borrego, Saverio Cinieri, E. Szombara, Laura García‐Estévez, N. Tubiana-Mathieu, Christelle Lévy, Marek Z. Wojtukiewicz, Rodolfo Passalacqua, A Ardizzoia, Roberto Hegg, Luis Fein, H. Simon, Eduardo Richardet, Joëlle Egreteau, Ornella Garrone, M. Morand, G. Villanova

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

    A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast... 由 Lori J. Goldstein, Mauro Mansutti, Christelle Lévy, Jenny C. Chang, Stéphanie Henry, I. Fernández-Pérez, Jana Prausová, Elżbieta Starosławska, Giuseppe Viale, Beth Butler, Susan McCanna, Pier Adelchi Ruffini, Max S. Wicha, Anne F. Schott, Ricardo H. Álvarez, Anne F. Schott, Maysa Abu‐Khalaf, Nuhad Ibrahim, Brooke Daniel, Michael W. Meshad, David E. Kanamori, Amelia Zelnak, Mark S. Graham, Jason E. Comer, Manon Huizing, François Duhoux, Vincent R. Richard, Didier Verhoeven, Martin Šmakal, Marta Krásenská, Milan Kohoutek, Martina Zimovjanová, Eugen Kubala, Mario Campone, Jean-­Marc Ferrero, Anthony Gonçalvès, Laurence Venat‐Bouvet, Jacques Médioni, Laura Biganzoli, Héctor Soto Parrà, Paolo Pedrazzoli, Marco Colleoni, Mauro Moroni, Dino Amadori, Paolo Morandi, Saverio Cinieri, Piotr Tomczak, Tomasz Sarosiek, Marek Z. Wojtukiewicz, Andrzej Mruk, Bożena Kukiełka-Budny, Silvia Antolín, Estela Vega Alonso, M. Martín Jiménez

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

    Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE) 由 Thomas Bachelot, Eva Ciruelos, Andreas Schneeweiß, Fabio Puglisi, Tamar Peretz‐Yablonski, Igor Bondarenko, Shani Paluch‐Shimon, Andrew Wardley, Jean-Louis Merot, Yolande Du Toit, V. Easton, Nicolas Lindegger, David Miles, Kamel Bouzid, Mario Campone, Bruno Coudert, Zbigniew Nowecki, Hassan Errihani, Florence Dalenc, Ana Ferreira, Max S. Mano, Francesco Ricci, Haralabos P. Kalofonos, Claudia Andreetta, Filippo Montemurro, Sophie Barrett, Qingyuan Zhang, Dimitris Mavroudis, Juan Antonio Matus, Carlos Beato, Xichun Hu, Rabab Gaafar, Hamdy Abdel Azeem, Christophe Perrin, Johannes Ettl, István Láng, Sunil Verma, Huiping Li, Étienne Brain, Oliver Hoffmann, Anna Cariello, Carlo Tondini, Taher Altwegeiri, Niklas Loman, Michael P. Lux, Antonio Frassoldati, Zeba Aziz, Fernando Palacios Salas, Joanna Streb, A Wroński, Salomón Menjón Beltrán, İrfan Çiçin, Peter Schmid, Robert Laing, Zhongsheng Tong, Katalin Boér, Balázs Juhász, Luca Gianni, Giuseppe Curigliano, Alejandro Juarez, Snežana Šušnjar, Erika Matos, Rüçhan Uslu, Hans Wildiers, Marcelo Cruz, Hugues Bourgeois, Raquel von Schumann, Salomon M. Stemmer, Flavia Morales Vásquez, Adriana Domínguez, Marek Z. Wojtukiewicz, Jasna Trifunović, José Juan Illarramendi, Laura García, Y. Izarzugaza Perón, María José Echarri, Natliia Voitko, Duncan Wheatley, Simon Waters, Richard de Boer, Guy Jérusalem, Véronique Cocquyt, Carlos H. Barrios, Lawrence Panasci, Johanna Mattson, Minna Tanner, M. Gozy, G. Vasilopoulos, János Révész, Luciano Latini, Cesare Gridelli, Jesus Miguel Lazaro, Antonio González, A. Barnadas Molins, Eduardo Martínez de Dueñas, Jesús Alarcón, Ana Arance, Leif Klint, Oleksiy Kovalyov, Richard D. Baird

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study

    Giredestrant for Estrogen Receptor–Positive, HER2-Negative, Previously Treated Advanced Breast Cancer: Results From the Randomized, Phase II acelERA Breast Cancer Study 由 Miguel Martín, Elgene Lim, Mariana Chávez‐MacGregor, Aditya Bardia, Jiong Wu, Qingyuan Zhang, Zbigniew Nowecki, Felipe José Silva Melo Cruz, R. N. Safin, Sung‐Bae Kim, Christian Schem, Alberto J. Montero, Sarah Khan, Reeti Bandyopadhyay, Heather M. Moore, Mahesh Shivhare, Monika Patre, Jorge Martinalbo, Laura Roncoroni, Pablo Perez-Moreno, Joohyuk Sohn, G. Aguil, Marcos E. Alfie, Valeria Cáceres, Guillermo Lerzo, Sandra A. Ostoich, F. Boyle, Elgene Lim, Hayes Martin, Catherine Oakman, Felipe Melo Cruz, Fábio Franke, André Mattar, E.H. Silva, Katsuki Arima Tiscoski, Wei Chen, Wěi Li, Zhongsheng Tong, Jing Wang, Shaomeng Wang, X. Wang, Jiong Wu, Xiao‐Yuan Wu, Ju Yang, Q. Zhang, Till‐Oliver Emde, G. Gaffunder, Carsten Hielscher, Michael P. Lux, Christian Schem, Manfred Welslau, Claudia Schumacher, I. Kuchuk, T Peretz, Larisa Ryvo, R. Yerushalmi, Hee Dong Chae, Y.S. Chae, Seock‐Ah Im, Hwa Jung Kim, Jie‐Hyun Kim, S.-B. Kim, Jung Eun Lee, Y. H. Park, Joohyuk Sohn, Michał Jarząb, Monika Nowaczyk, Zbigniew Nowecki, Tadeusz Pieńkowski, Marek Z. Wojtukiewicz, Piotr J. Wysocki, E. Fomin, I. P. Ganshina, Nikolay Kislov, М. В. Копп, Н. В. Коваленко, Y. Makarova, Marina Matrosova, Р. В. Орлова, Artem Poltoratsky, Р. Р. Сафин, Р. А. Зуков, A. Wong, Yoon Sim Yap, M.A. Coccia-Portugal, Nicolaas H. Fourie, R. Khanyile, L. Schoeman, Ta‐Chung Chao, S.-T. Chen, Wei‐Pang Chung, Yin‐Hsun Feng, Yung‐Chang Lin, Thitiya Dejthevaporn, Napa Parinyanitikul, Chirawadee Sathitruangsak, Areewan Somwangprasert, Piyawan Tienchaianada, Ahmet Alacacıoğlu, Efnan Algın

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: